Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
Deciding to Join Clinical Trials: Challenges and Motivations
Clinical & Pharma Deciding to Join Clinical Trials: Challenges and Motivations

The decision to participate in a clinical trial is a complex and deeply personal one, influenced by a myriad of factors. Patients and their families must navigate a landscape filled with medical, emotional, and logistical considerations. This article delves into the various challenges and

December 19, 2024
OIG Issues Fraud Alert on Medicare Advantage Marketing Schemes
Management & Administration OIG Issues Fraud Alert on Medicare Advantage Marketing Schemes

The Office of Inspector General (OIG) for the U.S. Department of Health and Human Services issued a special fraud alert on December 11, 2024, to address potentially fraudulent marketing activities linked to Medicare Advantage (MA) health plans, healthcare providers, and third-party marketers, such

December 18, 2024
Can Sensome's Clotild Guidewire Revolutionize PAD Treatment?
Clinical & Pharma Can Sensome's Clotild Guidewire Revolutionize PAD Treatment?

Imagine a technology capable of identifying 'fresh' blood clots in real time within patients suffering from peripheral artery disease (PAD), promising to revolutionize treatment and patient outcomes. This is precisely what Sensome's Clotild Smart Guidewire System aims to achieve,

December 17, 2024
How Will FDA's Approval Impact Pediatric Cardiac Care Innovations?
Clinical & Pharma How Will FDA's Approval Impact Pediatric Cardiac Care Innovations?

The recent FDA approval of Johnson & Johnson (J&J) MedTech’s Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps for pediatric use marks a significant milestone in pediatric cardiac care. This development opens new avenues for treating children with acute decompensated h

December 16, 2024
Global Plastics Treaty: Addressing Health and Ethical Imperatives
Clinical & Pharma Global Plastics Treaty: Addressing Health and Ethical Imperatives

Plastic pollution has emerged as one of the most pressing environmental and public health crises of our time. The pervasive presence of plastics in our environment, coupled with their detrimental health impacts, necessitates urgent global action. This article delves into the multifaceted issues

December 13, 2024
Revolutionizing Wearable Tech: Major Innovations Predicted for 2025
Tech & Innovation Revolutionizing Wearable Tech: Major Innovations Predicted for 2025

The wearable technology landscape is on the brink of a significant transformation. As we look forward to 2025, the advancements and trends in this sector promise to redefine how we interact with technology on a daily basis. Reflecting on the progress made in 2024, we can see the foundation being

December 12, 2024
Rising Safety Concerns in Elderly Care Prompt Calls for Reform
Care Providers Rising Safety Concerns in Elderly Care Prompt Calls for Reform

The topic of elderly care is becoming increasingly significant as recent incidents have raised concerns about the safety and well-being of seniors in various eldercare facilities across the United States. This comprehensive analysis focuses on the safety issues in assisted living and nursing homes,

December 10, 2024
How Will AI, Health Equity, and Telehealth Shape Healthcare by 2025?
Tech & Innovation How Will AI, Health Equity, and Telehealth Shape Healthcare by 2025?

The healthcare industry is on the brink of significant transformation, driven by advancements in technology, a focus on health equity, and the ongoing revolution in telehealth. Chris Frost, MD, the senior vice president, chief medical officer, and chief quality officer at Lifepoint Health, provides

December 9, 2024
Regulating T Cells: New Insights into Immune Response and Therapeutics
Clinical & Pharma Regulating T Cells: New Insights into Immune Response and Therapeutics

In a groundbreaking study conducted by researchers at the Peter Doherty Institute for Infection and Immunity, a significant discovery has been made, revealing a novel mechanism by which the body regulates a type of immune cell known as unconventional T cells. These cells are pivotal in mounting

December 3, 2024
New Tools for Enhancing Holistic Patient Care in Clinical Settings
Clinical & Pharma New Tools for Enhancing Holistic Patient Care in Clinical Settings

The healthcare landscape is evolving, with a growing emphasis on treating the "whole person" rather than just addressing physical symptoms. This shift is particularly evident in the Veterans Health Administration (VA), which is adopting a "Whole Health" approach to better meet

November 26, 2024
Loading
Latest articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later